Skye Bioscience Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Skye Bioscience Inc.
Former names: Emerald Bioscience, Inc. Nemus Bioscience, Inc. Load Guard Logistics, INC. Load Guard Transportation, INC.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Nevada
Headquarters city: SAN Diego
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: SKYE
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001516551
EIN: 45-0692882

Board of directors

Follow this board

Andrew J. Schwab · Director
Since 2023
Annalisa Jenkins · Director
Since 2024
Deborah H. Charych · Director
Since 2023
Karen L. Smith · Director
Since 2024
Keith Wayne Ward · Director
Since 2023
Margaret Dalesandro · Director
Since 2023
Paul A. Grayson · Director
Since 2023
Praveen Tyle · Director
Since 2023
Punit Dhillon · Director · Chief Executive Officer
Since 2023
Sukhwinder Singh Rai · Director
Since 2023

Chief executives

Punit Dhillon · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of May 26, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 8 other boards. 8 are in the same sector.

Shared director Other board Same sector

Aurinia Pharmaceuticals Inc Same sector
via Karen L. Smith
CAMP4 Therapeutics Corporation Same sector
via Andrew J. Schwab
COMPASS Pathways Plc Same sector
via Annalisa Jenkins
Context Therapeutics Inc. Same sector
via Karen L. Smith
Enliven Therapeutics Inc. Same sector
via Andrew J. Schwab
Kiora Pharmaceuticals Inc. Same sector
via Praveen Tyle
Mereo BioPharma Group plc Same sector
via Annalisa Jenkins
Tectonic Therapeutic Inc. Same sector
via Annalisa Jenkins

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $889,204; 30 sales by 4 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 23, 2026	5AM Ventures II LP 10% owner	Open-market sale	−114,851	$1.61	$184,910
Sep 23, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−114,851	$1.61	$184,910
Sep 23, 2026	5AM Ventures II LP 10% owner	Open-market sale	−4,528	$1.61	$7,290
Sep 23, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−4,528	$1.61	$7,290
Sep 22, 2026	5AM Ventures II LP 10% owner	Open-market sale	−27,612	$1.65	$45,560
Sep 22, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−27,612	$1.65	$45,560
Sep 22, 2026	5AM Ventures II LP 10% owner	Open-market sale	−1,088	$1.65	$1,795
Sep 22, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−1,088	$1.65	$1,795
Sep 16, 2026	Kush Parmar 10% owner	Open-market sale	−32,607	$1.91	$62,279
Sep 16, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−32,607	$1.91	$62,279
Sep 16, 2026	Kush Parmar 10% owner	Open-market sale	−1,285	$1.91	$2,454
Sep 16, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−1,285	$1.91	$2,454
Aug 20, 2026	5AM Partners II, LLC 10% owner	Open-market sale	−1,159	$0.32	$371
Aug 20, 2026	Andrew J. Schwab Director, 10% owner	Open-market sale	−1,159	$0.32	$371
Aug 20, 2026	5AM Partners II, LLC 10% owner	Open-market sale	−46	$0.32	$15

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Skye Bioscience Inc.

Who is the CEO of Skye Bioscience Inc.?

Punit Dhillon is Skye Bioscience Inc.'s Chief Executive Officer.

How many directors are on Skye Bioscience Inc.'s board?

Skye Bioscience Inc.'s board has 10 directors: Andrew J. Schwab, Annalisa Jenkins, Deborah H. Charych, Karen L. Smith, Keith Wayne Ward, Margaret Dalesandro, Paul A. Grayson, Praveen Tyle, Punit Dhillon and Sukhwinder Singh Rai.

Are Skye Bioscience Inc. insiders buying or selling shares?

Over the last 12 months, Skye Bioscience Inc. insiders made no open-market purchases and sold $889,204 of shares in 30 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Skye Bioscience Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="skye-bioscience-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.